The main mechanisms underlying the 1,5-AF-induced improvements in our animal models may comprise neurovascular protection and plasticity [27] and ischemic tolerance [28] caused by BDNF via AMPK/PGC-1α activity. The gene discussed is PPARGC1A; the disease is atrial fibrillation.